Senior insider sale
DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$624.4K
5.55K shares
What this filing means
READ SIMON plans to sell 5.55K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $624.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/10/2026ACC: 0001974158-26-000096
Director
Since May 2025
5.55K
Shares to sell
$624.4K
Approx. market value
5.55K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
N/A
5/22/2025
5.55KTotal acquired5.55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/22/2025 | Stock Option Exercise N/A | 5.55K | — |
| Total | 5.55K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.55K
Market value
$624.4K
8/10/2026
Total
Units
5.55K
Value
$624.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/10/2026 | 5.55K | $624.4K | NASDAQ | Planned |
| Total | 5.55K | $624.4K | ||